ChemoCentryx Up 70%, Lead Drug Meets Phase II Objective By: Benzinga via Benzinga December 12, 2014 at 10:37 AM EST ChemoCentryx Inc (NASDAQ: CCXI) gained more than 70 percent Friday on news that its lead drug candidate met with success in a Phase ... Read More >> Related Stocks: Chemocentryx Inc